Nanobiotix S.A. (NBTX)

Nanobiotix Statistics

Total Valuation

Nanobiotix has a market cap or net worth of $749.54 million. The enterprise value is $775.63 million.

Market Cap	749.54M
Enterprise Value	775.63M

Important Dates

The last earnings date was Tuesday, September 30, 2025, after market close.

Earnings Date	Sep 30, 2025
Ex-Dividend Date	n/a

Share Statistics

Nanobiotix has 48.21 million shares outstanding. The number of shares has increased by 10.33% in one year.

Current Share Class	n/a
Shares Outstanding	48.21M
Shares Change (YoY)	+10.33%
Shares Change (QoQ)	+0.03%
Owned by Insiders (%)	3.30%
Owned by Institutions (%)	6.00%
Float	30.86M

Valuation Ratios

PE Ratio	n/a
Forward PE	293.63
PS Ratio	62.82
Forward PS	10.10
PB Ratio	n/a
P/TBV Ratio	n/a
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	65.01
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 0.63

Current Ratio	0.63
Quick Ratio	0.58
Debt / Equity	n/a
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	-5.19

Financial Efficiency

Return on Equity (ROE)	n/a
Return on Assets (ROA)	-41.64%
Return on Invested Capital (ROIC)	-567.28%
Return on Capital Employed (ROCE)	245.90%
Revenue Per Employee	$110,470
Profits Per Employee	-$561,569
Employee Count	108
Asset Turnover	0.15
Inventory Turnover	n/a

Taxes

Income Tax	-43,453
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +282.35% in the last 52 weeks. The beta is 1.64, so Nanobiotix's price volatility has been higher than the market average.

Beta (5Y)	1.64
52-Week Price Change	+282.35%
50-Day Moving Average	15.83
200-Day Moving Average	7.16
Relative Strength Index (RSI)	44.97
Average Volume (20 Days)	142,107

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, Nanobiotix had revenue of $11.93 million and -$60.65 million in losses. Loss per share was -$1.28.

Revenue	11.93M
Gross Profit	11.93M
Operating Income	-51.59M
Pretax Income	-60.69M
Net Income	-60.65M
EBITDA	-51.49M
EBIT	-51.59M
Loss Per Share	-$1.28

Balance Sheet

The company has $33.84 million in cash and $60.18 million in debt, giving a net cash position of -$26.33 million or -$0.55 per share.

Cash & Cash Equivalents	33.84M
Total Debt	60.18M
Net Cash	-26.33M
Net Cash Per Share	-$0.55
Equity (Book Value)	-80.98M
Book Value Per Share	-1.68
Working Capital	-27.18M

Cash Flow

In the last 12 months, operating cash flow was -$36.55 million and capital expenditures -$595,420, giving a free cash flow of -$36.82 million.

Operating Cash Flow	-36.55M
Capital Expenditures	-595,420
Free Cash Flow	-36.82M
FCF Per Share	-$0.76

Margins

Gross Margin	100.00%
Operating Margin	-432.39%
Pretax Margin	-508.71%
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

Nanobiotix does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-10.33%
Shareholder Yield	-10.33%
Earnings Yield	-8.09%
FCF Yield	-4.91%

Analyst Forecast

The average price target for Nanobiotix is $8.00, which is -55.21% lower than the current price. The consensus rating is "Strong Buy".

Price Target	$8.00
Price Target Difference	-55.21%
Analyst Consensus	Strong Buy
Analyst Count	1
Revenue Growth Forecast (5Y)	n/a
EPS Growth Forecast (5Y)	n/a

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Nanobiotix has an Altman Z-Score of -2.82 and a Piotroski F-Score of 1. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	-2.82
Piotroski F-Score	1